RedHill Biopharma reported $1.29M in Sales Revenues for its fiscal quarter ending in June of 2024.





Sales Change Date
Clal Biotechnology ILS 3.41M 2M Dec/2022
Compugen USD 1.89M 631K Sep/2025
Cronos Group USD 36.34M 2.88M Sep/2025
RedHill Biopharma USD 1.29M 722K Jun/2024